The impact of glycemic control on progressive forms of non-alcoholic fatty liver disease: combined data from multiple clinical trials including more than 5000 patients (in collaboration with NAIL-NIT consortium)

被引：0

作者：

Noureddin, Mazen ^{[1
]}

Dubourg, Julie ^{[2
]}

Schattenberg, Joern ^{[3
]}

Charlton, Michael ^{[4
]}

Harrison, Stephen ^{[5
]}

Alkhouri, Naim ^{[6
]}

Megnien, Sophie Jeannin ^{[7
]}

Ratziu, Vlad ^{[8
]}

机构：

[1] Houston Methodist Hosp, Houston, TX USA

[2] Summit Clin Res, San Antonio, TX USA

[3] Univ Med Johannes Gutenberg Univ Mainz, Mainz, Germany

[4] UChicago Med, Chicago, IL USA

[5] Univ Oxford, Oxford, England

[6] Arizona Liver Hlth, Chandler, AZ USA

[7] Summit Clin Res, Summit, NJ USA

[8] Inst Cardiometab & Nutr, Paris, France

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-438

引用

页码：S619 / S619

页数：1

共 31 条

[1] Glycated hemoglobin as an independent predictor of hepatocyte ballooning in non-alcoholic steatohepatitis: combined data from multiple clinical trials including more than 5000 patients (in collaboration with NAIL-NIT consortium)
Harrison, Stephen
Dubourg, Julie
Megnien, Sophie Jeannin
Schattenberg, Joern
Ratziu, Vlad
Charlton, Michael
Alkhouri, Naim
Noureddin, Mazen
JOURNAL OF HEPATOLOGY, 2023, 78 : S619 - S620
[2] Comparison of non-alcoholic steatohepatitis severity between Hispanics and non-Hispanics: combined data from multiple therapeutic clinical trials including more than 5000 patients (in collaboration with NAIL-NIT consortium)
Megnien, Sophie Jeannin
Dubourg, Julie
Schattenberg, Joern
Ratziu, Vlad
Harrison, Stephen
Noureddin, Mazen
Alkhouri, Naim
Charlton, Michael
JOURNAL OF HEPATOLOGY, 2023, 78 : S643 - S643
[3] Deep dive analysis into the screening failure reasons: combined data from multiple therapeutic clinical trials including more than 5000 patients (in collaboration with NAIL-NIT consortium)
Schattenberg, Jorn
Dubourg, Julie
Noureddin, Mazen
Alkhouri, Naim
Ratziu, Vlad
Charlton, Michael
Megnien, Sophie Jeannin
Harrison, Stephen
JOURNAL OF HEPATOLOGY, 2023, 78 : S604 - S605
[4] Performance of the AGA clinical care pathway in identifying patients with at-risk non-alcoholic steatohepatitis: combined data from multiple therapeutic clinical trials including more than 5,000 patients (in collaboration with NAIL-NIT consortium)
Alkhouri, Naim
Dubourg, Julie
Harrison, Stephen
Charlton, Michael
Ratziu, Vlad
Schattenberg, Jorn
Megnien, Sophie Jeannin
Noureddin, Mazen
JOURNAL OF HEPATOLOGY, 2023, 78 : S31 - S31
[5] DESCRIPTION OF DIVERSITY IN NONALCOHOLIC STEATOHEPATITIS (NASH) CLINICAL TRIALS: COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS ( IN COLLABORATION WITH NAIL-NIT CONSORTIUM)
Alkhouri, Naim
Jeannin, Sophie
Dubourg, Julie
Schattenberg, Joern M.
Rich, Nicole E.
Harrison, Stephen A.
Noureddin, Mazen
HEPATOLOGY, 2023, 78 : S939 - S943
[6] Performance of non-invasive tests as exclusion criteria for cirrhosis in trials targeting at-risk non-alcoholic steatohepatitis: combined data from multiple trials including more than 5,000 patients (in collaboration with NAIL-NIT consortium)
Alkhouri, Naim
Dubourg, Julie
Harrison, Stephen
Noureddin, Mazen
Charlton, Michael
Ratziu, Vlad
Megnien, Sophie Jeannin
Schattenberg, Joern
JOURNAL OF HEPATOLOGY, 2023, 78 : S655 - S656
[7] Performance of vibration controlled transient elastography and related scores to identify at-risk non-alcoholic steatohepatitis patients: combined data from multiple trials including more than 5,000 patients (in collaboration with NAIL-NIT consortium)
Noureddin, Mazen
Dubourg, Julie
Harrison, Stephen
Megnien, Sophie Jeannin
Ratziu, Vlad
Charlton, Michael
Alkhouri, Naim
Schattenberg, Jorn
JOURNAL OF HEPATOLOGY, 2023, 78 : S31 - S32
[8] AGE HAS INDEPENDENT POSITIVE AND NEGATIVE ASSOCIATIONS WITH ADVANCED FIBROSIS AND STEATOSIS: COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS ( IN COLLABORATION WITH NAIL-NIT CONSORTIUM)
Harrison, Stephen A.
Dubourg, Julie
Jeannin, Sophie
Alkhouri, Naim
Schattenberg, Jorn M.
Noureddin, Mazen
HEPATOLOGY, 2023, 78 : S913 - S916
[9] METABOLIC CONTROL WORSENS WITH INCREASING FIBROSIS STAGE IN PATIENTS WITH PRE-CIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH): COMBINED DATA FROM MULTIPLE THERAPEUTIC CLINICAL TRIALS INCLUDING MORE THAN 6,000 PATIENTS (WITH THE COLLABORATION OF NAIL-NIT CONSORTIUM)
Schattenberg, Joern M.
Dubourg, Julie
Harrison, Stephen A.
Alkhouri, Naim
Jeannin, Sophie
Noureddin, Mazen
HEPATOLOGY, 2023, 78 : S1006 - S1009
[10] CLINICAL, BIOLOGICAL AND IMAGING PREDICTORS OF AT-RISK METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS (IN COLLABORATION WITH NAIL-NIT CONSORTIUM)
Harrison, Stephen A.
Dubourg, Julie
Alkhouri, Naim
Noureddin, Mazen
Schattenberg, Joern M.
Jeannin, Sophie
HEPATOLOGY, 2023, 78 : S249 - S253

← 1 2 3 4 →